Luken Investment Analytics »

Regeneron Pharmaceuticals shares owned by Luken Investment Analytics

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Luken Investment Analytics from 13F filings

Historical chart of Luken Investment Analytics investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Luken Investment Analytics consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Luken Investment Analytics

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.2k 8 771.88

More positions owned by Luken Investment Analytics

First Tr Exchange-traded Ft Vest Tec (TDVI)
First Tr Exchange-traded First Tr Enh New (FTSM)
First Tr Exchange-traded Ft Vest Gold (IGLD)
Spdr Series Trust State Street Spd (SPYM)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
First Tr Exchange-traded Ft Vest Ris (RDVI)
Ssga Active Tr State Street Bla (HYBL)
First Tr Exchng Traded Fd Vi Ft Vest Int June (YJUN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Series Trust State Street Spd (SPYG)

View all positions for Luken Investment Analytics

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Franklin Resources
Geode Capital Management
Nuveen
FMR
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management

View all funds holding Regeneron Pharmaceuticals